Experienced global leaders from multinational companies who have brought more than 20 Innovative biologics to the market worldwide. Management team with proven track record of generating $5B+ in partnering R&D and commercial revenue.

Growing preclinical and clinical pipeline with greater than 10 programs. Proprietary platforms to create cutting edge biologics.

Partnering business model to maximize portfolio value. Global Business Development and Alliance Management capabilities with 9 partnerships to date.